Cabergoline Aspire Pharma

Cabergoline Aspire Pharma is a medication used primarily for conditions related to high prolactin levels. This oral medication is manufactured by Aspire Pharma Limited and is available in the EU market.

Cabergoline is commonly used to manage conditions associated with elevated prolactin levels, such as hyperprolactinemia. It may also be prescribed for conditions like Parkinson's disease or certain menstrual disorders. The medication works by reducing the amount of prolactin in the body, which can help alleviate related symptoms.

Common effects of Cabergoline may include nausea, dizziness, and headaches. Some users might experience digestive issues or fatigue. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Cabergoline should be handled with care, especially by individuals with a history of heart disease or high blood pressure. It is important to follow the prescribed dosage and avoid sudden changes in medication without medical advice. Pregnant or breastfeeding women should consult a healthcare provider before use.

Cabergoline may interact with certain medications, including those that affect blood pressure or other dopamine-related drugs. Alcohol consumption should be moderated, as it can enhance the sedative effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.